Related Experiment Video
Updated: May 15, 2026
07:41
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
Pattern Visual Evoked Potentials in Patients with Type II Diabetes Mellitus
Javad Heravian1, Akram Ehyaei, Nasser Shoeibi
1Department of Optometry, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran.
Journal of Ophthalmic & Vision Research
|December 25, 2012
Summary
Pattern visual evoked potentials (PVEP) show longer P100 wave latency in diabetic patients, indicating early retinal ganglion cell damage. This method may detect prediabetic retinopathy before visible signs appear.
Area of Science:
- Ophthalmology
- Neurology
- Endocrinology
Background:
- Diabetes mellitus is a systemic disease affecting multiple organs, including the eyes.
- Diabetic retinopathy is a leading cause of vision loss, but early detection remains challenging.
- Visual evoked potentials (VEP) assess the integrity of the visual pathway, from the retina to the visual cortex.
Purpose of the Study:
- To evaluate cortical and retinal activity using pattern visual evoked potentials (PVEP) in patients with type II diabetes mellitus.
- To determine if PVEP can detect subclinical visual pathway dysfunction in diabetics before ophthalmoscopic signs of retinopathy.
Main Methods:
- PVEP was recorded in 40 diabetic patients (20 with non-proliferative diabetic retinopathy [NPDR], 20 without retinopathy) and 40 healthy controls.
- Comparison of P100 wave latency and N75/P100 amplitudes between groups.
- Analysis of correlation between VEP parameters and glycemic control (HbA1c) or diabetes duration.
Main Results:
- Diabetic patients exhibited significantly longer P100 wave latency compared to controls (P<0.001).
- Both diabetic groups (with and without retinopathy) showed increased P100 latency versus controls.
- Significant reductions in N75 (P=0.037) and P100 (P=0.001) amplitudes were observed in diabetics.
Conclusions:
- Increased PVEP latency suggests early retinal ganglion cell damage in diabetes, preceding visible retinopathy.
- PVEP is a sensitive tool for detecting pre-clinical diabetic retinopathy.
- Early detection via PVEP may help in preventing diabetic eye complications.
Related Concept Videos
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...